Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.0772 CHF -3.02% Market Closed
Market Cap: 14.2m CHF
Have any thoughts about
Addex Therapeutics Ltd?
Write Note

Addex Therapeutics Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Addex Therapeutics Ltd
Accrued Liabilities Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Addex Therapeutics Ltd
SIX:ADXN
Accrued Liabilities
CHf628.2k
CAGR 3-Years
-34%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Accrued Liabilities
$39.1m
CAGR 3-Years
48%
CAGR 5-Years
51%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Accrued Liabilities
CHf11.9m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Accrued Liabilities
$108.3m
CAGR 3-Years
9%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Accrued Liabilities
CHf12m
CAGR 3-Years
-22%
CAGR 5-Years
-9%
CAGR 10-Years
5%
Kuros Biosciences AG
SIX:KURN
Accrued Liabilities
CHf8.7m
CAGR 3-Years
49%
CAGR 5-Years
37%
CAGR 10-Years
N/A

See Also

What is Addex Therapeutics Ltd's Accrued Liabilities?
Accrued Liabilities
628.2k CHF

Based on the financial report for Jun 30, 2024, Addex Therapeutics Ltd's Accrued Liabilities amounts to 628.2k CHF.

What is Addex Therapeutics Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
-22%

Over the last year, the Accrued Liabilities growth was -55%. The average annual Accrued Liabilities growth rates for Addex Therapeutics Ltd have been -34% over the past three years , -22% over the past five years .

Back to Top